Cat. No. 2585
Biological ActivityComplement inhibitor; binds C3 inhibiting proteolytic cleavage by C3 convertase (IC50 = 28 μM) and activation of classical and alternative complement pathways (IC50 values are 63 and 12 μM respectively). Prolongs graft survival and reduces hyperacute rejection of ex vivo pig kidneys perfused with human blood and inhibits in vivo heparin/protamine-induced complement activation in baboons. Control peptide available (Cat. No. 3796).
(Modifications: Thr-13 = C-terminal amide, Disulfide bridge between 2 - 12)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Sahu et al (1996) Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J.Immunol. 157 884. PMID: 8752942.
Fiane et al (1999) Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation 6 52. PMID: 10355733.
Soulika et al (2000) Inhibition of heparin/protamine complex-induced complement activation by compstatin in baboons. Clin.Immunol. 96 212. PMID: 10964539.
If you know of a relevant citation for this product please let us know.
View Related Products by Product Action
Keywords: Compstatin, supplier, C3-binding, protein, inhibits, inhibitors, complement, activation, Convertase, Tocris Bioscience, Complement
Find multiple products by catalog number
New Products in this Area
Potent and selective GRK2/3 inhibitorPMX 53c
Negative control for PMX 53 (Cat. No. 5473)W 54011
High affinity C5a receptor antagonistTDFA
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.